AR activation involves the binding of androgens to the receptor, which then translocates to the cell nucleus and binds to specific DNA sequences known as androgen response elements (AREs). This binding leads to the transcription of genes that promote cell cycle progression, survival, and proliferation. In cancer, mutations or amplifications of the AR gene can alter its activity, making cancer cells more aggressive and resistant to therapies.
